Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells

Dong Woo Kang1,2, Shin Wha Lee1,3, Won Chan Hwang2

  • 1Institute of Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Cancer Research
|October 30, 2016
PubMed

Insights

Phospholipase D1 (PLD1) links key cancer pathways in colorectal cancer. Targeting PLD1 promotes apoptosis and may offer a new therapeutic strategy for colon cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • The RB1/E2F1 pathway is frequently altered in colorectal cancer (CRC).
  • Potential links between RB1/E2F1, Wnt/β-catenin, and PI3K/Akt pathways in CRC are suggested but lack molecular evidence.

Purpose of the Study:

  • To investigate the role of phospholipase D1 (PLD1) in mediating interactions between major signaling pathways in colorectal cancer development.
  • To explore PLD1 as a potential therapeutic target in colon cancer.

Main Methods:

  • Utilized the Apcmin/+ mouse model for intestinal tumorigenesis studies.
  • Investigated PLD1's role in apoptosis, cell survival, and cancer-initiating cell self-renewal.
  • Analyzed the miR-192/4465-RB1 axis and Akt-TopBP1 pathways.
  • Correlated PLD1-driven E2F1 target gene expression with tumor stage in CRC patients.

Main Results:

  • PLD1, a β-catenin/TCF4 target, orchestrates functional interactions between Wnt/β-catenin, PI3K/Akt, and RB1/E2F1 pathways.
  • PLD1 overexpression protected intestinal cells from apoptosis in the Apcmin/+ model.
  • Targeting PLD1 induced E2F1-dependent apoptosis via miR-192/4465-mediated RB1 downregulation and Akt-TopBP1 inhibition.
  • PLD1 also contributed to colon cancer-initiating cell self-renewal through the miRNA-RB1 axis and Akt pathway.
  • PLD1-driven E2F1 target gene expression correlated with advanced colorectal cancer stage.

Conclusions:

  • PLD1 acts as a crucial signaling node, mediating cross-talk between major pathways to enhance colon cancer cell survival and malignancy.
  • PLD1 represents a promising therapeutic target for colorectal cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K